1. Home
  2. COCP vs CYCU Comparison

COCP vs CYCU Comparison

Compare COCP & CYCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • CYCU
  • Stock Information
  • Founded
  • COCP 2006
  • CYCU N/A
  • Country
  • COCP United States
  • CYCU United States
  • Employees
  • COCP N/A
  • CYCU N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • CYCU
  • Sector
  • COCP Health Care
  • CYCU
  • Exchange
  • COCP Nasdaq
  • CYCU Nasdaq
  • Market Cap
  • COCP 15.7M
  • CYCU 13.1M
  • IPO Year
  • COCP N/A
  • CYCU N/A
  • Fundamental
  • Price
  • COCP $1.80
  • CYCU $0.38
  • Analyst Decision
  • COCP Strong Buy
  • CYCU
  • Analyst Count
  • COCP 1
  • CYCU 0
  • Target Price
  • COCP $6.00
  • CYCU N/A
  • AVG Volume (30 Days)
  • COCP 21.6K
  • CYCU 2.8M
  • Earning Date
  • COCP 08-13-2025
  • CYCU 08-15-2025
  • Dividend Yield
  • COCP N/A
  • CYCU N/A
  • EPS Growth
  • COCP N/A
  • CYCU N/A
  • EPS
  • COCP N/A
  • CYCU N/A
  • Revenue
  • COCP N/A
  • CYCU $17,398,680.00
  • Revenue This Year
  • COCP N/A
  • CYCU N/A
  • Revenue Next Year
  • COCP N/A
  • CYCU N/A
  • P/E Ratio
  • COCP N/A
  • CYCU N/A
  • Revenue Growth
  • COCP N/A
  • CYCU N/A
  • 52 Week Low
  • COCP $1.12
  • CYCU $0.26
  • 52 Week High
  • COCP $3.26
  • CYCU $10.99
  • Technical
  • Relative Strength Index (RSI)
  • COCP 69.71
  • CYCU N/A
  • Support Level
  • COCP $1.46
  • CYCU N/A
  • Resistance Level
  • COCP $1.60
  • CYCU N/A
  • Average True Range (ATR)
  • COCP 0.08
  • CYCU 0.00
  • MACD
  • COCP 0.02
  • CYCU 0.00
  • Stochastic Oscillator
  • COCP 92.31
  • CYCU 0.00

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About CYCU Cycurion Inc. Common Stock

Cycurion Inc. provides information technology security solutions through its subsidiaries. The Company continually strives to deliver top-notch services in risk management, cybersecurity, information assurance, systems engineering, and help desk solutions. The company generates the majority of its revenue from Advisory Consulting services, with small portion revenue generated from Managed Security Service Practice (MSSP) and Software as a Service (Saas).

Share on Social Networks: